Health
Development of a Unique Rapid Test to Detect Anti-bodies Directed Against an Extended RBD of SARS-CoV-2 Spike Protein – DocWire News
Chimia (Aarau). 2021 May 28;75(5):446-452. doi: 10.2533/chimia.2021.446.ABSTRACTSerological testing for antibodies directed against SARS-CoV-2 in patients
Chimia (Aarau). 2021 May 28;75(5):446-452. doi: 10.2533/chimia.2021.446.
ABSTRACT
Serological testing for antibodies directed against SARS-CoV-2 in patients may serve as a diagnostic tool to verify a previous infection and as surrogate for an elicited humoral immune response, ideally conferring immunity after infection or vaccination. Here, we present the recombinant expression of an extended receptor binding domain (RBD) of the SARS-CoV-2 Spike protein used as capture antigen in a unique rapid…
-
General13 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Noosa News20 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
Business21 hours agoBell Potter names the best ASX shares to buy in October
-
General18 hours agoAustralia welcomes Gaza peace progress, hostage release